Germline mutations in the BRCAI gene cause inherited susceptibility to brea
st and ovarian cancers. However, somatic mutations of BRCAI are rare in spo
radic breast and ovarian tumours. To establish whether BRCAI is altered dur
ing the development of sporadic ovarian cancer by mechanisms other than som
atic mutation, we have analysed 57 sporadic epithelial ovarian tumours for
BRCAI protein and RNA expression. Reduced or absent protein expression was
observed in 90% of tumours. Decreased protein expression was significantly
associated with a reduction in the levels of RNA expression. Somatic mutati
ons of BRCAI and LOH at the BRCAI locus were detected in 3.5% and 44% of in
formative tumours, respectively; there was no significant correlation betwe
en the levels of protein and RNA expression and the DNA mutation and/or LOH
status. Together, these data suggest that expression of BRCAI is down-regu
lated at the level of transcription during the development of sporadic ovar
ian cancers. Int. J. Cancer 87:317-321, 2000. (C) 2000 Wiley-Liss, Inc.